Sunday, February 1, 2026
23.6 C
Bengaluru

Anup Soans

Reach out to Anup Soans: anupsoans@medicinman.net.

Quality, Not Price: Why the Generic Drug Debate Keeps Missing the Point

In an earlier article in The Wire Science, I argued that India’s debate on generic medicines is routinely misframed....

IQVIA vs. PharmaTrac: Indian Pharma Market Data

Here is an analytical blog comparing the IQVIA MFR Dec 2025 report with the previously reviewed PharmaTrac Dec 2025...

Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead

The latest PharmaTrac report for December 2025 offers a compelling snapshot of the Indian Pharmaceutical Market (IPM) at a...

Orphan Drugs and Indian Pharma: Moving from Volume to Value?

Zydus’ ZYCUBO May Be the Proof Point the Industry Needed For decades, Indian pharma has won by playing the volume...

Arjun Arunachalam: The Man Who Deleted Helium

For more than fifty years, the MRI industry treated liquid helium as destiny. Superconducting magnets needed it. End of discussion. Arjun...

Who Is Monitoring Quality in India’s Small Drug Units?

The Telangana Drugs Control Administration’s stop-use notice on a paediatric syrup contaminated with ethylene glycol should not be framed...
spot_imgspot_img

Zydus vs. Helsinn — What It Really Means for Indian Pharma

On December 24, 2025, the Delhi High Court delivered a ruling that, while technical on its face, carries deep...

Worldclass Healthcare But Out of Reach for Most Indians?

When an eminent cardiologist like Dr. Sunil Chandy—former Director at CMC Vellore—calls out the "medical colonialism and exploitation that...

Managed Healthcare – Better Choice for India?

Managed care shifts healthcare from fragmented fee-for-service models to coordinated, prevention-focused systems, delivering better outcomes and cost control. Proven...

Indian Pharma November Sales: What Do They Say?

IQVIA's Market Feedback Report (MFR) and PharmaTrac's Acquaint report both analyze the Indian Pharmaceutical Market (IPM) for November 2025,...

Cipla–Pfizer Deal: How “Ordinary” Brands Are Fueling an Extraordinary Power Shift in Indian Pharma

What’s really happening in the Cipla–Pfizer tie‑up At first glance, the announcement looks modest: Cipla gets exclusive rights to market...

Alok Sonig Appointed CEO of Rosemont Pharmaceuticals

Effective January 1, 2026, Rosemont Pharmaceuticals has announced the appointment of Alok Sonig as its new Chief Executive Officer,...